Patient Safety & Outcomes

Cancer patients and other people taking immune-suppressing medications do not have an overall higher risk of dying from COVID-19, according to a study involving more than 200,000 hospitalized COVID-19 patients. 

As the U.S. enters its regular flu season, there's still a lot unknown about coinfection of flu and SARS-CoV-2 viruses. 

People taking certain antidepressants, particularly fluoxetine, may have a lower death risk from COVID-19, according to research published Nov. 15 in JAMA Network Open.

Medical understanding of pulmonary arterial hypertension (PAH) has come a long way in the last 20 years.1,2 Today, the medical community has a much clearer picture of the pathophysiology of this disease.1

The number of patients hospitalized for COVID-19 at Henry Ford Health System has increased by nearly 60 percent since late October, the Detroit-based system said Nov. 16.

Medicare Advantage members who frequented providers with value-based care arrangements spent significantly less time in a hospital than non-value-based members. 

The combination of staffing shortages, longer patient stays and unmet behavioral health needs is leaving Massachusetts hospitals bracing for "yet another difficult winter," according to the head of the state's hospital association.

In 2019, three-fourths of the country's 201,092 sepsis-related deaths were among people aged 65 and older, according to a report from the CDC's National Center for Health Statistics published Nov. 10. 

The American Hospital Association released its latest edition of the COVID-19 Snapshot Nov. 11, underscoring the persisting challenges hospitals face amid the pandemic.

Presbyterian Healthcare Services and University of New Mexico Health activated crisis standards of care Nov. 11 for their Albuquerque metro hospitals, which are facing challenges managing patient needs amid a COVID-19 surge.